A detailed history of Quinn Opportunity Partners LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 212,141 shares of CTLT stock, worth $12.8 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
212,141
Previous 568,928 62.71%
Holding current value
$12.8 Million
Previous $32.1 Million 62.86%
% of portfolio
1.42%
Previous 3.68%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $19.1 Million - $20.3 Million
-356,787 Reduced 62.71%
212,141 $11.9 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $24.2 Million - $34 Million
568,928 New
568,928 $32.1 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Quinn Opportunity Partners LLC Portfolio

Follow Quinn Opportunity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.